Kawasaki disease complicated by macrophage activation syndrome treated with canakinumabKawasaki disease treated with canakinumab

Netea et al. present an infant with macrophage activation syndrome as part of Kawasaki disease, who was first treated with canakinumab, followed by methylprednisolone and IVIG. Despite early treatment, giant coronary artery aneurysms developed transiently, questioning the singular role of IL-1 in KD...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Stejara A. Netea, Diana van Stijn, Mariken P. Gruppen, J. Merlijn van den Berg, Nico A. Blom, Irene M. Kuipers, Taco W. Kuijpers
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Rockefeller University Press 2026-04-01
coleção:	Journal of Human Immunity
Acesso em linha:	https://rupress.org/jhi/article-pdf/doi/10.70962/jhi.20250240/2029932/jhi_20250240.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!